NCT00902538
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
See it on ClinicalTrials.gov ↗808 people
42%
58%
339 womenmiddle line = equal numbers469 men
- Phase
- PHASE3
- Paid for by
- Daiichi Sankyo
- Finished
- 2010-10
- Health conditions
- Essential Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 55.8 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 30.34 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 99.9% · Asian 0.1% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Black / African American 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Female subjects of childbearing potential who are pregnant or lactating.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Female subjects of childbearing potential who are pregnant or lactating.”
- No women who could get pregnant
Most women roughly 15–50 years old were turned away.
“Female subjects of childbearing potential who are pregnant or lactating.”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Subjects with secondary hypertension of any aetiology such as renal disease, phaeochromocytoma, or Cushing's syndrome.”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Subjects having a history of the following within the last six months: myocardial infarction (MI), unstable angina pectoris, percutaneous coronary intervention, heart failure, hypertensive encephalopathy, cerebrovascular accident (stroke),…”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“…rebrovascular, cardiovascular, renal, respiratory, hepatic, gastrointestinal, endocrine or metabolic, haematological or oncological, neurological, and psychiatric diseases. The same applies for immunocompromised and/or neutropenic subjects.”
- No cancer
Women with current or past cancer were turned away.
“…rebrovascular, cardiovascular, renal, respiratory, hepatic, gastrointestinal, endocrine or metabolic, haematological or oncological, neurological, and psychiatric diseases. The same applies for immunocompromised and/or neutropenic subjects.”
Study titles and rules are shown in their original English.